Skip to content
MedsAcross

Medicine

Fludrocortisone 0.1 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Fludrocortisone 0.1 mg tablet is a generic prescription medicine for oral use, made by 15 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Fludrocortisone
Brand
Sold under the generic name
Strength
0.1 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 1000 tablets and 23 more
Manufacturers
Viona PharmaceuticalsIndiaZydus LifesciencesIndiaAmneal Pharmaceuticals of New YorkNovitium PharmaAmerican Health PackagingAmneal Pharmaceuticals NYCardinal HealthEywa PharmaMajor PharmaceuticalsAvKARE
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
H02AA02 Fludrocortisone
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
18 March 2002
Identifiers
RxCUI 313979DailyMed set ID 3d6f1a89-ea11-474d-aaca-64fea02a3beb, eff2eae8-94ce-46ca-a027-6b1d08e7b96b, bc92f5c6-3a65-4fab-85b3-fd5b84f917c1 +13NDC 71335-2454, 71930-088, 72578-164 +13Application ANDA215279, ANDA220308, ANDA219251 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle72578-164-01Viona PharmaceuticalsIndia2 December 2024
500 tablet in 1 bottle72578-164-05Viona PharmaceuticalsIndia2 December 2024
100 tablet in 1 bottle70771-1893-1Zydus LifesciencesIndia2 December 2024
500 tablet in 1 bottle70771-1893-5Zydus LifesciencesIndia2 December 2024
100 tablet in 1 bottle69238-7033-1Amneal Pharmaceuticals NY18 March 2002
500 tablet in 1 bottle69238-7033-5Amneal Pharmaceuticals NY18 March 2002
100 tablet in 1 bottle0115-7033-01Amneal Pharmaceuticals of New York18 March 2002
500 tablet in 1 bottle0115-7033-02Amneal Pharmaceuticals of New York18 March 2002
1000 tablet in 1 bottle0115-7033-03Amneal Pharmaceuticals of New York18 March 2002
100 tablet in 1 bottle71930-088-12Eywa Pharma2 June 2025
500 tablet in 1 bottle71930-088-52Eywa Pharma2 June 2025
30 tablet in 1 bottle70954-252-10Novitium Pharma2 June 2022
100 tablet in 1 bottle70954-252-20Novitium Pharma2 June 2022
500 tablet in 1 bottle70954-252-30Novitium Pharma2 June 2022
10 blister pack in 1 bag / 1 tablet in 1 blister pack55154-2644-0Cardinal Health25 February 2025
10 blister pack in 1 bag / 1 tablet in 1 blister pack55154-6645-0Cardinal Health9 May 2008
100 blister pack in 1 box, unit-dose / 1 tablet in 1 blister pack68084-288-01American Health Packaging5 September 2008
50 blister pack in 1 carton / 1 tablet in 1 blister pack68084-288-65American Health Packaging9 February 2023
100 tablet in 1 bottle42291-764-01AvKARE13 January 2021
50 blister pack in 1 box, unit-dose / 1 tablet in 1 blister pack50268-330-15AvPAK1 August 2011
100 tablet in 1 bottle71335-2454-1Bryant Ranch Prepack30 July 2024
100 tablet in 1 bottle51407-705-01Golden State Medical Supply10 June 2025
50 blister pack in 1 carton / 1 tablet in 1 blister pack0904-7317-06Major Pharmaceuticals4 September 2024
100 blister pack in 1 carton / 1 tablet in 1 blister pack0904-7317-61Major Pharmaceuticals4 September 2024
100 tablet in 1 bottle72603-170-01NorthStar Rx7 September 2023
30 tablet in 1 blister pack0615-6562-39Vangard Labs7 October 2020

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 18 August 1955Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Clinical summary

Fludrocortisone is a prescription medicine indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison’s disease and for the treatment of salt-losing adrenogenital syndrome. It is available as tablets for oral use. MedsAcross supplies Fludrocortisone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Fludrocortisone

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Fludrocortisone 0.1 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.